help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dodge, K. L.
Right arrow Articles by Sanborn, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dodge, K. L.
Right arrow Articles by Sanborn, B. M.
Endocrinology Vol. 140, No. 11 5165-5170
Copyright © 1999 by The Endocrine Society

ARTICLES

Protein Kinase A Anchoring to the Myometrial Plasma Membrane Is Required for Cyclic Adenosine 3',5'-Monophosphate Regulation of Phosphatidylinositide Turnover1

Kimberly L. Dodge, Daniel W. Carr and Barbara M. Sanborn

Department of Biochemistry and Molecular Biology, University of Texas Medical School, Houston, Texas 77030; and the Department of Medicine, Veterans Affairs Medical Center and Oregon Health Science University (D.W.C.), Portland, Oregon 97201

Address all correspondence and requests for reprints to: Barbara M. Sanborn, Ph.D., Department of Biochemistry and Molecular Biology, University of Texas Medical School, P.O. Box 20708, Houston, Texas 77225. E-mail: bsanborn{at}bmb.med.uth.tmc.edu

The importance of the localization of protein kinase A (PKA) to the plasma membrane for cAMP-mediated inhibition of phosphatidylinositide turnover was tested in an immortalized pregnant human myometrial (PHM1–41) cell line, and the putative A kinase anchoring protein (AKAP) involved was identified. Preincubation in PHM1–41 cells with chlorophenylthio-cAMP (CPT-cAMP), forskolin, or relaxin inhibited the ability of oxytocin to stimulate phosphatidylinositide turnover. The addition of a peptide that specifically disrupts interactions of PKA RII subunits with AKAPs (S-Ht31) reversed the effects of these agents, whereas a control peptide was ineffective. The pharmacology of S-Ht31 on this particular membrane event was further characterized. A 10-min incubation with S-Ht31 at a concentration of 1 µM completely reversed the inhibitory effect of relaxin on phosphatidylinositide turnover. S-Ht31 inhibited cAMP-stimulated PKA activity in PHM1–41 cell plasma membranes and decreased the concentration of PKA. Overlay analysis detected a single AKAP of approximately 86 kDa associated with the plasma membrane of PHM1–41 cells, suggesting that the association of PKA with this AKAP is important for the cAMP inhibitory mechanism. The mol wt of this AKAP was similar to that of an AKAP associated with the plasma membrane in the human brain, AKAP79. Antibodies against AKAP79 recognized a band at 86 kDa in purified plasma membranes from the PHM1–41 cells, indicating similar determinants in these proteins. These data suggest that PKA is anchored to the myometrial plasma membrane through association with an AKAP similar to AKAP79, and that this anchoring is required for the cAMP-mediated inhibition of phosphatidylinositide turnover in PHM1–41 cells.




This article has been cited by other articles:


Home page
 Biol. Reprod.Home page
M. Zhong, D. A. Murtazina, J. Phillips, C.-Y. Ku, and B. M. Sanborn
Multiple Signals Regulate Phospholipase CBeta3 in Human Myometrial Cells
Biol Reprod, June 1, 2008; 78(6): 1007 - 1017.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P. Ciarmela, E. Wiater, and W. Vale
Activin-A in Myometrium: Characterization of the Actions on Myometrial Cells
Endocrinology, May 1, 2008; 149(5): 2506 - 2516.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
R. A. Bathgate, R. Ivell, B. M. Sanborn, O. D. Sherwood, and R. J. Summers
International Union of Pharmacology LVII: Recommendations for the Nomenclature of Receptors for Relaxin Family Peptides.
Pharmacol. Rev., March 1, 2006; 58(1): 7 - 31.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
B. M. Sanborn, C.-Y. Ku, S. Shlykov, and L. Babich
Molecular Signaling Through G-Protein-Coupled Receptors and the Control of Intracellular Calcium in Myometrium
Reproductive Sciences, October 1, 2005; 12(7): 479 - 487.
[Abstract] [PDF]

Home page
 Mol. Endocrinol.Home page
B. T. Nguyen and C. W. Dessauer
Relaxin Stimulates Protein Kinase C {zeta} Translocation: Requirement for Cyclic Adenosine 3',5'-Monophosphate Production
Mol. Endocrinol., April 1, 2005; 19(4): 1012 - 1023.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
O. D. Sherwood
Relaxin's Physiological Roles and Other Diverse Actions
Endocr. Rev., April 1, 2004; 25(2): 205 - 234.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
A. W. Ayres, D. W. Carr, D. S. McConnell, R. W. Lieberman, and G. D. Smith
Expression and Intracellular Localization of Protein Phosphatases 2A and 2B, Protein Kinase A, A-Kinase Anchoring Protein (AKAP79), and Binding of the Regulatory (RII) Subunit of Protein Kinase A to AKAP79 in Human Myometrium
Reproductive Sciences, October 1, 2003; 10(7): 428 - 437.
[Abstract] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Malcolm. W. J. MacDougall, G. N. Europe-Finner, and Stephen. C. Robson
Human Myometrial Quiescence and Activation during Gestation and Parturition Involve Dramatic Changes in Expression and Activity of Particulate Type II (RII{alpha}) Protein Kinase A Holoenzyme
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2194 - 2205.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. L. Dell'Acqua, K. L. Dodge, S. J. Tavalin, and J. D. Scott
Mapping the Protein Phosphatase-2B Anchoring Site on AKAP79. BINDING AND INHIBITION OF PHOSPHATASE ACTIVITY ARE MEDIATED BY RESIDUES 315-360
J. Biol. Chem., December 6, 2002; 277(50): 48796 - 48802.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. den Dekker, G. Gorter, J. W. M. Heemskerk, and J.-W. N. Akkerman
Development of Platelet Inhibition by cAMP during Megakaryocytopoiesis
J. Biol. Chem., August 2, 2002; 277(32): 29321 - 29329.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
C.-Y. Ku and B. M. Sanborn
Progesterone Prevents the Pregnancy-Related Decline in Protein Kinase A Association with Rat Myometrial Plasma Membrane and A-Kinase Anchoring Protein
Biol Reprod, August 1, 2002; 67(2): 605 - 609.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
A. A. Abdel-Latif
Cross Talk Between Cyclic Nucleotides and Polyphosphoinositide Hydrolysis, Protein Kinases, and Contraction in Smooth Muscle
Experimental Biology and Medicine, March 1, 2001; 226(3): 153 - 163.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
K. L. Dodge, D. W. Carr, C. Yue, and B. M. Sanborn
A Role for AKAP (A Kinase Anchoring Protein) Scaffolding in the Loss of a Cyclic Adenosine 3',5'-Monophosphate Inhibitory Response in Late Pregnant Rat Myometrium
Mol. Endocrinol., December 1, 1999; 13(12): 1977 - 1987.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
D. W. Carr, A. Fujita, C. L. Stentz, G. A. Liberty, G. E. Olson, and S. Narumiya
Identification of Sperm-specific Proteins That Interact with A-kinase Anchoring Proteins in a Manner Similar to the Type II Regulatory Subunit of PKA
J. Biol. Chem., May 11, 2001; 276(20): 17332 - 17338.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society